BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15687885)

  • 1. Helminths and the modulation of mucosal inflammation.
    Elliott DE; Summers RW; Weinstock JV
    Curr Opin Gastroenterol; 2005 Jan; 21(1):51-8. PubMed ID: 15687885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helminths and mucosal immune modulation.
    Weinstock JV
    Ann N Y Acad Sci; 2006 Aug; 1072():356-64. PubMed ID: 17057216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helminths as governors of immune-mediated inflammation.
    Elliott DE; Summers RW; Weinstock JV
    Int J Parasitol; 2007 Apr; 37(5):457-64. PubMed ID: 17313951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helminths and inflammatory bowel diseases].
    Laclotte C; Oussalah A; Rey P; Bensenane M; Pluvinage N; Chevaux JB; Trouilloud I; Serre AA; Boucekkine T; Bigard MA; Peyrin-Biroulet L
    Gastroenterol Clin Biol; 2008 Dec; 32(12):1064-74. PubMed ID: 18619749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for helminths in the therapy of inflammatory bowel disease?
    Summers RW; Elliott DE; Weinstock JV
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):62-3. PubMed ID: 16265104
    [No Abstract]   [Full Text] [Related]  

  • 7. Where are we on worms?
    Elliott DE; Weinstock JV
    Curr Opin Gastroenterol; 2012 Nov; 28(6):551-6. PubMed ID: 23079675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy. Can worms tame the immune system?
    Wickelgren I
    Science; 2004 Jul; 305(5681):170-1. PubMed ID: 15247451
    [No Abstract]   [Full Text] [Related]  

  • 9. Trichuris suis ova: testing a helminth-based therapy as an extension of the hygiene hypothesis.
    Jouvin MH; Kinet JP
    J Allergy Clin Immunol; 2012 Jul; 130(1):3-10; quiz 11-2. PubMed ID: 22742834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichuris suis excretory secretory products (ESP) elicit interleukin-6 (IL-6) and IL-10 secretion from intestinal epithelial cells (IPEC-1).
    Parthasarathy G; Mansfield LS
    Vet Parasitol; 2005 Aug; 131(3-4):317-24. PubMed ID: 15978725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
    Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
    J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases?
    Erb KJ
    Trends Immunol; 2009 Feb; 30(2):75-82. PubMed ID: 19138565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic and molecular mechanisms in inflammatory bowel disease.
    Ince MN; Elliott DE
    Surg Clin North Am; 2007 Jun; 87(3):681-96. PubMed ID: 17560420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity in inflammatory bowel disease: state of the art.
    Hisamatsu T; Ogata H; Hibi T
    Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency.
    Mannon PJ; Fuss IJ; Dill S; Friend J; Groden C; Hornung R; Yang Z; Yi C; Quezado M; Brown M; Strober W
    Gastroenterology; 2006 Sep; 131(3):748-56. PubMed ID: 16952544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB in inflammatory bowel disease.
    Atreya I; Atreya R; Neurath MF
    J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of action of probiotics.
    Boirivant M; Strober W
    Curr Opin Gastroenterol; 2007 Nov; 23(6):679-92. PubMed ID: 17906447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate antimicrobial immunity in inflammatory bowel diseases.
    Beisner J; Stange EF; Wehkamp J
    Expert Rev Clin Immunol; 2010 Sep; 6(5):809-18. PubMed ID: 20828289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.